Sign up
An elderly couple is smilingly sitting with a drink in the kitchen
Heart, blood vessels and metabolism Now open for registration

Easi-Protkt: prevention of heart failure

In this study, we examine whether a new drug, together with empagliflozin, can help prevent serious health problems in people with type 2 diabetes, high blood pressure, and cardiovascular diseases.
Age 18+ years old
Stadium Type 2 diabetes, high blood pressure and cardiovascular diseases
Duration 2.5 to 4 years
Location All locations

Who can participate in this study?

Fixed conditions apply to this research. The following are stated in plain language.

You can participate if

  • You are 40 years old or older
  • You have type 2 diabetes and are currently receiving treatment for it
  • You have a cardiovascular disease
  • You have high blood pressure

If you are unsure whether you meet these conditions, you can still register. We will then look together to see if you are eligible to participate.

Consultation with us

What is this research about?

The goal of this study is to examine whether the investigational drug, in combination with the medication empagliflozin, can help people with type 2 diabetes, high blood pressure, and cardiovascular diseases. We want to investigate whether this combination can reduce the risk of developing serious health problems. Empagliflozin has already been approved in the Netherlands for the treatment of type 2 diabetes and to reduce the risk of death from cardiovascular diseases in people with type 2 diabetes.

This study examines the effect of the investigational drug in combination with empagliflozin, compared with a placebo (a dummy drug without active ingredients).

The combination of the investigational drug + empagliflozin is being studied as a possible treatment for type 2 diabetes, high blood pressure, and cardiovascular diseases. For this purpose, we are collecting information on events related to the heart and blood vessels. As soon as enough data is collected on these types of events, we can assess whether the investigational drug actually reduces the risk of cardiovascular problems.

The exact length of time you participate in the study depends on when you start. The final date for the study is the same for everyone, regardless of when you start.

The number of visits you make to the research center depends on how long you participate.

The research takes place in Amsterdam, Den Bosch or Zwolle.

What you can expect from us

  • You are always the first priority – everything we do revolves around you.
  • Experienced team of doctors, neuropsychologists and nurses.
  • Open and welcoming atmosphere – this makes you feel at home quickly and allows you to relax.
  • Clarity – an expert in drug research, ensuring that you are well informed throughout all steps and that you can always contact us if you have any questions.

What does it bring me?

  • You may experience positive effects from a new treatment.
  • You will be under the control of a specialized team of healthcare professionals. They can provide you with advice and monitor whether there is a change in your daily functioning.
  • You actively contribute to the development of medicines for cardiovascular diseases

This is how to participate, step by step

1

You register

A two-minute form: name, phone number, email address, place of residence and diagnosis. No medical questions. You are only asking for information with this form.

An older woman sits at the kitchen table at home with a tablet and smiles

Costs

  • Joining doesn't cost you anything.
  • Travel and parking costs are reimbursed.
  • If you come during lunchtime, you will receive a meal.
  • Participation is outside your health insurance; your own contribution is not charged.

Take the first step

Two minutes, at home. After registering, you will hear from us within a week.

Where is this research being conducted?

This research is being conducted at three of our three locations. You choose the location that works best for you.

Amsterdam

Amsterdam

Cronenburg 2, 1081 GN Amsterdam

020 301 7170
Den Bosch

Den Bosch

Statenlaan 37, 5223 LA Den Bosch

073 200 4111
Zwolle

Zwolle

Dokter Stolteweg 90, 8025 AZ Zwolle

038 202 6120

Frequently asked questions

I am already taking other medications; can I continue taking them?

Yes, you can continue to use your current medications. After your registration, we will carefully review your current medication use. If you use many (heavy) medications, that may be a reason not to allow you to participate in a study, but this varies per study. In no case should you stop using your current medications.

Will the regular treatment by my current specialist (cardiologist/internist etc.) continue during participation in drug trials? Or will Progress Clinical Research take over this?

The regular treatment by your current specialist (cardiologist/internist etc.) will generally continue during the period of the study. Progress Clinical Research will inform your specialist and GP about your participation. During the study, checks will be performed at several points. If there are any abnormal results, Progress Clinical Research, with your consent, will contact your GP or treating specialist. Your GP or specialist may also discuss changes in your health with one of our research doctors on a low-threshold basis.

Does Progress Clinical Research also seek participants without symptoms or without a diagnosis to participate in drug trials?

Progress Clinical Research mainly conducts research on patients who have already been diagnosed, but we sometimes also conduct studies where healthy volunteers are sought. So you can also sign up if no diagnosis has been made.

Can I stop the research early or are there any conditions attached?

Yes, stopping can be done at any time. There are no conditions attached to this.

Progress Clinical Research has several drug trials: can I choose which trial I am interested in?

Yes, you can read about the ongoing studies on our website. You can also indicate a preference for a particular study: for example, would you prefer to participate in a short study (for example, a few months) or a long study (for example, several years)? Progress Clinical Research determines, among other things, based on your medical history, age, and current medication use whether you are suitable for the study of your preference. Different criteria apply for each study, and the possibilities are discussed with the study doctor. Participation in a study is always done in consultation.

What does participating in a study actually mean?

Steps to follow when participating in research:

  • Sign up Sign up with Progress Clinical Research.
  • Telephone intake and request of medical history You will be called for a telephone intake, information about Progress Clinical Research will be sent to you and you will receive a form to sign in order to request the medical history from the treating physician (this history is necessary to determine whether you are eligible for the study).
  • Choosing an introductory meeting and a study: If your medical history with Progress Clinical Research shows no objections to participating in the study, we schedule an introductory meeting of approximately half an hour with the pre-screening specialist and the study doctor. In this meeting, we will get to know each other in more detail and mutually express preferences and expectations. Next, you will receive detailed information about a number of drug studies to take home, so that you can read it calmly at home and possibly discuss it with family or friends. Then you choose which study you would like to participate in.
  • Screening During the screening, various tests are performed to determine whether you are eligible to participate in the drug trial. Sometimes the examination only involves a series of questions, while other tests may require laboratory tests. These tests are always performed in consultation with and with your consent. This screening takes between one and a half to three hours and varies depending on the drug trial. Based on the results, it is determined whether you are eligible to participate in the chosen drug trial or not. Since each trial has different criteria for participation, you may be eligible to participate in another trial. Each trial has different criteria for participation.
  • Randomization In drug research, some of the patients receive the active drug. The other part of the patients receives a placebo. A placebo is a drug without active ingredients. The patients are randomly placed in a group by a computer. Both the patients and the Brain Research Center do not know who is in which group. This way, the research results can be compared well: does the group that receives the real drug perform the same, better, or worse than the placebo group? As soon as the drug study is completed by all participants, you will be informed whether you received the active drug or the placebo.
  • Follow-up appointments: Once the screening has been completed, follow-up appointments are scheduled. The number of appointments and the duration of the appointments vary per drug study. On average, patients come to Progress Clinical Research 1 to 2 times per month for a half-hour to several hours visit. At Progress Clinical Research, you will receive more information during the initial meeting. The documentation that you receive when you leave the clinic also includes how often you visit the Brain Research Center during the study. When scheduling the appointments, we of course take as much into account as possible regarding your and your partner’s work schedules and vacation plans, but we also ask for flexibility on your part.
  • After the investigation: Once you have gone through the entire investigation, the results are reviewed: Have you remained stable, moved forward, or actually regressed? Subsequently, we can decide together whether to continue with an investigation or conclude your period of employment with Progress Clinical Research.
Can I participate in a study more often?

Yes, that is possible. If you have completed the entire study, the results are reviewed: Have you remained stable, progressed, or actually regressed? Subsequently, we can decide together whether to continue with the study or conclude your period of employment at Progress Clinical Research.

Is there a financial reimbursement for patients?

All patients receive reimbursement for travel and parking costs automatically. Lunch is also provided for longer visits. There is no other financial reimbursement. You participate in a clinical drug trial because the medicines offer you the chance to improve and because you want to help future generations. Another benefit of participating in a research study is that your disease is monitored closely and you receive good guidance and support from professionals during the study.

What does randomization mean?

In some clinical drug trials, some of the patients receive the active drug. The other part of the patients receives a placebo. A placebo is a drug without active substances. The patients are randomly placed in a group by a computer. Both the patients and the doctors do not know who is in which group. However, there are also drug trials where no placebo is used; all the patients receive the study drug.

What does blindness mean?

A computer randomly places the patients in a group. One group receives the active drug, the other group receives a placebo. A placebo is a drug without active ingredients. No one involved in the research knows which group you belong to. This is called blinding.

What do the medicines look like?

The investigational medication often comes in the form of tablets. You can take them at home daily. Depending on the type of drug being studied, the medication may also be administered every few weeks via an injection or infusion. This is done at Progress Clinical Research under the supervision of a doctor.

Do I always have a chance of getting a placebo?

In most drug trials, there is indeed a medicinal product that is active and a medicinal product that is not active (placebo). Progress Clinical Research has no control over the allocation of the funds: this happens automatically and Progress Clinical Research does not receive that information either. Only in acute emergencies can Progress Clinical Research request this information. There are also a number of drug trials that use only active substances. During an initial consultation, the research doctor can inform you about this.

Will my health insurance’s deductible be applied if I participate in a study by Progress Clinical Research?

No, the treatments at Progress Clinical Research are not covered by health insurance. Therefore, you do not have to worry about any out-of-pocket costs. For each drug trial, an individual insurance policy is taken out for all participants. If you have any questions about this, please ask during the initial consultation or during the initial meeting. Please note that other matters, such as follow-up visits with your own specialist (outside of Progress Clinical Research), are still covered by your own health insurance.

Other studies on heart, blood vessels and metabolism

All studies

Is this research not relevant? These studies within the same disease area are now also looking for participants.

An older man is reading the newspaper at the kitchen table Heart, blood vessels and metabolism

BaxDuo: prevention of heart failure

In this study, we examine whether the combination of baxdrostat and dapagliflozine reduces the risk of heart failure…

Heart failure Amsterdam Den Bosch Zwolle

*Would you prefer to call? We will take the time to answer your questions.

A woman holds a bouquet of flowers in the sunlight Heart, blood vessels and metabolism

Redefine

The REDEFINE study looks at whether a new drug, CagriSema, can help with weight loss. During the study, patients…

Obesity 18+ years old Den Bosch

*Would you prefer to call? We will take the time to answer your questions.

A woman laughs loudly at a light window Heart, blood vessels and metabolism

AMAZING: ObesityFull

The goal of this study is to investigate whether NNC0487-0111 is safe and can help…

Obesity 18 to 55 years old Den Bosch

An investigator will call you within a week.